The Effect of Acceptance and Commitment Therapy in Patients With Chronic Renal Failure
1 other identifier
interventional
32
1 country
1
Brief Summary
Psychological flexibility, life satisfaction and adaptation to the disease of individuals with chronic kidney disease were increased with psychoeducation based on acceptance and commitment therapy to be given to individuals with chronic kidney disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedFirst Submitted
Initial submission to the registry
April 5, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2024
CompletedApril 26, 2024
April 1, 2024
6 months
April 5, 2024
April 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Chronic Disease Adaptation Scale (CHAS):
The scale, which consists of three sub-dimensions (physical adaptation, social adaptation, psychological adaptation) and 25 items, is a 5-point Likert scale (1: Strongly Disagree, 2: Disagree, 3: Undecided, 4: Agree, 5: Strongly Agree).The total score obtained from the scale is 125. The increase in the scores obtained from the sub-dimensions and/or the whole scale means that the patients' level of adaptation to the disease increases.
8 weeks
Acceptance and Action Questionnaire-II Scale (AAQ-II)
The KEF-II is a 7-point Likert-type self-report scale consisting of a total of 7 items. Scale items are graded from 1 ("Never true") to 7 ("Always true"). The lowest score that can be obtained from the scale is 7 and the highest score is 49. Higher total scores indicate an increase in the level of psychological rigidity, while lower scores indicate an increase in the level of psychological flexibility.
8 weeks
Life Satisfaction Scale
The scale consisting of five questions is in the form of a five-point Likert scale ranging from '1=not at all appropriate' to '5=very appropriate'. The lowest score that can be obtained from the scale, which has no sub-dimensions, is 5 and the highest score is 25. The high score obtained from the scale indicates a high degree of satisfaction.
8 weeks
Study Arms (2)
control groups
NO INTERVENTIONNo intervention was performed in chronic renal failure patients with eGFH values below 29 ml/dl/1.72m.
intervention groups
EXPERIMENTALAn 8-session acceptance and commitment therapy-based psychoeducation was applied to chronic renal failure patients with eGFH values below 29 ml/dl/1.72m
Interventions
psychoeducation based on acceptance and commitment therapy prepared by the researchers was applied individually to the patients
Eligibility Criteria
You may qualify if:
- Acceptance to participate in the research
- Diagnosis of CKD Stage 4-5
- GFR below 29ml/min/1.72m2
- years of age and over
- Being literate
- No barriers to verbal communication
- No psychiatric treatment
You may not qualify if:
- Receiving haemodialysis and peritoneal dialysis treatment,
- Pregnancy
- The presence of a psychiatric disorder requiring treatment,
- Individuals with transplantation and rejection transplantation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Recep Tayyip Erdoğan University Faculty of Health Sciences
Rize, Güneysu, 53100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
kübra berber
Recep Tayyip Erdogan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- LECTURER
Study Record Dates
First Submitted
April 5, 2024
First Posted
April 10, 2024
Study Start
June 1, 2023
Primary Completion
November 30, 2023
Study Completion
July 30, 2024
Last Updated
April 26, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share